OppenheimerFunds’s Amedisys AMED Stock Holding History

OppenheimerFunds’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$26.3M	Buy	213,370 +44,699	+27%	+$5.61M	0.03%	469
2018 Q4	$19.8M	Sell	168,671 -160,593	-49%	-$18.9M	0.03%	508
2018 Q3	$41.1M	Sell	329,264 -179,930	-35%	-$19.9M	0.05%	385
2018 Q2	$43.5M	Sell	509,194 -47,443	-9%	-$3.48M	0.05%	356
2018 Q1	$33.6M	Buy	556,637 +241	+0%	+$13.7K	0.04%	419
2017 Q4	$29.3M	Sell	556,396 -7,703	-1%	-$406K	0.04%	463
2017 Q3	$31.6M	Sell	564,099 -105,171	-16%	-$5.56M	0.04%	426
2017 Q2	$42M	Buy	669,270 +223,123	+50%	+$13M	0.05%	342
2017 Q1	$22.8M	Buy	446,147 +15,289	+4%	+$729K	0.03%	539
2016 Q4	$18.4M	Buy	430,858 +69,585	+19%	+$2.96M	0.02%	599
2016 Q3	$17.1M	Buy	361,273 +349,570	+2,987%	+$17.4M	0.02%	612
2016 Q2	$591K	Sell	11,703 -1,549	-12%	-$78.2K	﹤0.01%	1167
2016 Q1	$641K	Sell	13,252 -2,321	-15%	-$89.6K	﹤0.01%	1134
2015 Q4	$612K	Buy	+15,573	New	+$623K	﹤0.01%	1205

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

OppenheimerFunds's AMED Position: Q1 2019 in Review

OppenheimerFunds increased its Amedisys (AMED) stake by 27% in Q1 2019, buying an estimated $5.61M and bringing the position to 213,370 shares worth $26.3M. The position accounts for 0.03% of the portfolio, ranked #469.

OppenheimerFunds first reported a position in AMED in Q4 2015 and has held it in 14 quarters since. The position peaked at $43.5M in Q2 2018. 317 funds tracked by Wall St. Rank hold AMED as of Q1 2019.

OppenheimerFunds held 213,370 shares of Amedisys worth $26.3M as of Q1 2019.
OppenheimerFunds bought 44,699 Amedisys shares in Q1 2019, an estimated $5.61M.
Amedisys made up 0.03% of OppenheimerFunds's portfolio in Q1 2019, its #469 holding.
OppenheimerFunds first reported a position in Amedisys in Q4 2015 and has held it in 14 quarters since.
OppenheimerFunds's Amedisys position peaked at $43.5M in Q2 2018.
317 funds tracked by Wall St. Rank held Amedisys as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.